This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MaxLinear Says Silicon Laboratories Patent Lawsuit Is Without Merit

MaxLinear, Inc., a leading provider of integrated radio frequency and mixed-signal semiconductor solutions for broadband communications applications, said today that, based on its initial investigation, the July 18 patent infringement lawsuit against the company by Silicon Laboratories lacks merit.

Last May, MaxLinear filed its own complaint in U.S. District Court against Silicon Labs, seeking a declaratory judgment to obtain a ruling that MaxLinear products do not infringe nineteen patents owned by Silicon Laboratories. The declaratory judgment complaint further seeks a ruling that the Silicon Labs patents are invalid.

The Silicon Labs complaint filed yesterday appears to be part of that company’s continuing pattern of making false accusations against the company. MaxLinear contends that Silicon Laboratories filed this patent infringement lawsuit in hopes of disrupting the company’s customer relationships and obscuring the reality that their products cannot match the features and performance of MaxLinear’s products.

About MaxLinear, Inc.

MaxLinear, Inc. is a leading provider of integrated radio-frequency and mixed-signal semiconductor solutions for broadband communications applications. MaxLinear is located in Carlsbad, California, and its address on the Internet is www.maxlinear.com.

MxL and the MaxLinear logo are trademarks of MaxLinear, Inc. Other trademarks appearing herein are the property of their respective owners.

Cautionary Note About Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of federal securities laws. Forward-looking statements include, among others, statements concerning or implying anticipated litigation results, future financial performance, or trends and growth opportunities affecting MaxLinear. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by these forward-looking statements. In particular, intellectual property litigation is expensive and may result in a diversion of management’s time and attention, both of which could adversely affect our future operating results. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in MaxLinear’s filings with the United States Securities and Exchange Commission (SEC), including risks and uncertainties identified in our Annual Report on Form 10-K for the year ended December 31, 2011 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2012. All forward-looking statements are qualified in their entirety by this cautionary statement. MaxLinear is providing this information as of the date of this release and does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs